锦欣生殖(01951.HK):5月12日至15日合计回购488.2万股
格隆汇5月15日丨锦欣生殖(01951.HK)发布公告,2020年5月12日至5月15日,根据购回授权,公司分别按最高价每股10.00港元及最低价每股9.42港元于联交所购买合共488.2万股股份。已付股份购回的购买价合共4785.25万港元。根据股份购回所购回的股份占紧接股份购回前公司已发行股份总数约0.20%。公司将其后注销购回股份。
公告表示,公司财务状况稳健,并认为股份的当前成交价格并未反映其内在价值及公司的业务前景。因此,董事会相信股份购回可提高股份价值,藉以提升公司股东的回报。此外,股份购回反映公司对其业务发展及行业长远前景的信心。鉴于以上所述,董事会认为股份购回符合公司及股东的整体利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.